News + Filings Transactions
|
Holtzman Douglas
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 07/03/2023 | Icosavax, Inc. | ICVX | Sale | Common Stock | 14.3k | $8.74 | $124.7k | | 07/03/2023 |
| 07/03/2023 | Icosavax, Inc. | ICVX | Sale | Common Stock | 2.1k | $9.59 | $20.1k | | 07/03/2023 |
| 07/03/2023 | Icosavax, Inc. | ICVX | Exercise | Stock Option (Right to Buy) | 16.4k | $1.04 | $17k | | 07/03/2023 |
| 04/03/2023 | Icosavax, Inc. | ICVX | Sale | Common Stock | 20.1k | $6.08 | $122.4k | | 04/03/2023 |
| 04/03/2023 | Icosavax, Inc. | ICVX | Sale | Common Stock | 300 | $6.56 | $2k | | 04/03/2023 |
| 04/03/2023 | Icosavax, Inc. | ICVX | Exercise | Stock Option (Right to Buy) | 20.4k | $1.04 | $21.3k | | 04/03/2023 |
| 12/15/2022 | Icosavax, Inc. | ICVX | Sale | Common Stock | 19.6k | $11.14 | $219k | By Stanley Holtzman | 12/15/2022 |
| 11/10/2022 | Icosavax, Inc. | ICVX | Grant | Stock Option (Right to Buy) | 82.6k | $2.47 | $204k | | 11/10/2022 |
| 08/02/2022 | Icosavax, Inc. | ICVX | Sale | Common Stock | 453 | $6.70 | $3k | | 07/29/2022 |
| 08/01/2022 | Icosavax, Inc. | ICVX | Sale | Common Stock | 9.3k | $6.64 | $62k | | 07/29/2022 |
| 07/29/2022 | Icosavax, Inc. | ICVX | Sale | Common Stock | 585 | $7.11 | $4.2k | | 07/29/2022 |
| 02/18/2022 | Icosavax, Inc. | ICVX | Gift | Common Stock | 20k | $0.00 | $0 | By Stanley Holtzman | 07/29/2022 |
| 02/10/2022 | Icosavax, Inc. | ICVX | Grant | Stock Option (Right to Buy) | 82k | $17.55 | $1.4M | | 02/10/2022 |
| 02/10/2022 | Icosavax, Inc. | ICVX | Grant | Common Stock | 19.5k | $0.00 | $0 | | 02/10/2022 |
| 12/31/2021 | Icosavax, Inc. | ICVX | Gift | Common Stock | 10k | $0.00 | $0 | By Stanley Holtzman | 02/10/2022 |
| 08/02/2021 | Icosavax, Inc. | ICVX | Conversion | Common Stock | 52.4k | $0.00 | $0 | By Stanley Holtzman | 07/30/2021 |
| 08/02/2021 | Icosavax, Inc. | ICVX | Conversion | Series A-1 Preferred Stock | 206.3k | $0.00 | $0 | By Stanley Holtzman | 07/30/2021 |
| 08/02/2021 | Icosavax, Inc. | ICVX | Conversion | Series B-1 Preferred Stock | 11.6k | $0.00 | $0 | By Stanley Holtzman | 07/30/2021 |
| 07/30/2021 | Icosavax, Inc. | ICVX | Grant | Common Stock | 41.5k | $15.00 | $622.5k | | 07/30/2021 |
|